Checks out so far.

“In a randomized controlled trial of 249 physicians in Indonesia, Kenya, and the Netherlands, GPT-4o access improved clinical-performance scores relative to control by 18 percentage points in Kenya, 10.7 in Indonesia, and 7.2 in the Netherlands under controlled conditions; harms were not assessed.”

2 of 4 review checks done · 1 counted · 1 by the author only

Supported · 0.9468 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited. The number is model-conditional, not a share of truth.